dioscorealide B: an anti-allergic agent isolated from Dioscorea membranacea; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Dioscorea | genus | A plant genus best known for edible underground tubers. Yam may also refer to a moist variety of sweet potato, IPOMOEA BATATAS.[MeSH] | Dioscoreaceae | The yam plant family, of the order Liliales, has thick roots or tubers and net-veined, heart-shaped leaves that sometimes are lobed.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 11044777 |
MeSH ID | M0506207 |
Synonym |
---|
dioscorealide b |
(6s)-6-hydroxy-5,10-dimethoxy-3,7-dioxatetracyclo[6.6.2.04,15.012,16]hexadeca-1(15),4,8(16),9,11,13-hexaen-2-one |
Dioscorealide B is an active compound from the rhizome of Dioscorea. Pierre which locally known as "Hua-Khao-Yen"
Excerpt | Reference | Relevance |
---|---|---|
"Dioscorealide B is an active compound from the rhizome of Dioscorea membranacea Pierre which locally known as "Hua-Khao-Yen". " | ( Cytotoxic effect and its mechanism of dioscorealide B from Dioscorea membranacea against breast cancer cells. Dechsukum, C; Graidist, P; Itharat, A; Saekoo, J, 2010) | 2.07 |
"Dioscorealide B is a pharmacologically active compound from the rhizome of the Thai medicinal plant Dioscorea membranacea. " | ( Dioscorealide B from the traditional Thai medicine Hua-Khao-Yen induces apoptosis in MCF-7 human breast cancer cells via modulation of Bax, Bak and Bcl-2 protein expression. Dechsukum, C; Graidist, P; Itharat, A; Leeanansaksiri, W; Saekoo, J, 2010) | 3.25 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |